Mr. Speaker, I sent the attached letter, along with my colleagues, in support of Gulf War Veterans Illnesses Research funding in the Conference Report of the Defense Appropriations Bill on November 10, 2005. Congress of the United States,…
Mr. Speaker, I sent the attached letter, along with my colleagues, in support of Gulf War Veterans Illnesses Research funding in the Conference Report of the Defense Appropriations Bill on November 10, 2005.
Congress of the United States,
Washington, DC, November 10, 2005.
The Hon. C.W. Bill Young,
Chairman, Appropriations Subcommittee on Defense, H-309 U.S.
Capitol, Washington, DC.
The Hon. John P. Murtha,
Ranking Member, Appropriations Subcommittee on Defense, 1016
Longworth House Office Building, Washington, DC.
Dear Chairman Young and Ranking Member Murtha: As the
conferees begin to work on the fiscal year 2006
Appropriations bill for the Subcommittee on Defense, we
respectfully seek your support for retaining the House
funding level of $10 million for Gulf War Veterans Illnesses
research.
The Congressionally chartered Veterans' Administration
Research Advisory Committee on Gulf War Veterans' Illnesses
found in September 2004 that fourteen years after the 1990-
1991 Gulf War, between 26 and 32 percent of those who served
in that war continue to suffer from serious and persistent
health problems--typically multiple symptoms that include
severe headaches, memory problems, muscle and joint pain,
severe gastrointestinal problems, respiratory problems, skin
disorders and other problems. They also determined that the
existence of these serious and often debilitating problems
could not be scientifically explained by stress or
psychiatric illness.
We are only now starting to see the long-term effects. For
example, ALS, or Lou Gehrig's disease, occurs in Persian Gulf
veterans with twice the frequency of peer veterans that were
not deployed. Yet a federal research program to better
understand these issues that was once $45 million strong has
been virtually eliminated. The FY 06 budget dedicates no
funding to either the Department of Defense or the Department
of Health and Human Services for Gulf War Illnesses research.
The funding we are requesting is consistent with the VA
Research Committee recommendations.
The amendment to the FY 06 House Defense appropriations
bill that added the research funding was well supported. It
passed by voice vote, had bipartisan support and was backed
by the American Legion, Paralyzed Veterans of America, the
National Gulf War Resource Center, Vietnam Veterans of
America, and Veterans of Foreign Wars.
Finally, research guidance was developed in consultation
with top members of the VA Research Committee. We therefore
request that the guidance, which is the same as that inserted
into the congressional record during bill debate, be included
in the conference report. The guidance text is attached for
your reference. We expect this research to supplement the
other promising research performed at Army Research,
Development, Test and Evaluation within the Department of
Defense.
Thank you for consideration of our requests.
Sincerely,
Dennis J. Kucinich, Bernard Sanders, Frank Pallone, Jr.,
Jim McDermott, Lane Evans, Tammy Baldwin, Christopher
Shays, Rob Simmons, Rush D. Holt, Barbara Lee, Albert
R. Wynn, Carolyn B. Maloney, Lloyd Doggett, Joseph
Crowley, Raul Grijalva, John Conyers, Jr., Jay Inslee,
Dennis Moore, Collin C. Peterson, Betty McCollum, Ed
Case, Members of Congress.
Gulf War Veterans' Illnesses Research Guidance for the FY06 Defense
Department Appropriations Conference Report
It is intended that the appropriation for research on
chronic illnesses affecting veterans of the 1991 Gulf War be
used for a coherent research program focusing on (1)
identification of mechanisms underlying Gulf War illnesses,
(2) chronic effects of neurotoxic substances to which
veterans were exposed during deployment; (3) studies that
expand on earlier research identifying neurological and
immunological abnomalities in ill Gulf War veterans; and (4)
identification of promising treatments. The primary objective
of the research program will be to elucidate
pathophysiological mechanisms underlying Gulf War illnesses,
which may subsequently be targeted to developing treatments
for these conditions. A further objective will be to identify
and evaluate treatments which currently exist and which hold
promise for treating these illnesses.
The U.S. Army Medical Research and Materiel Command shall,
in consultation with experienced research scientists in
relevant fields, establish a list of research questions to
address the above topics, and design a program of specific
research studies that together constitute a coherent plan to
answer these questions, each identified study to be conducted
by the most qualified researcher, which may include consulted
scientists. As part of this process, there shall be a public
solicitation of research proposals (which may include concept
exploration and pilot projects) on these questions and at
least twenty-five percent of the program (measured by amount
funded) shall be made up of proposals selected from this
solicitation, as modified if necessary to increase the value
of the proposed research to the overall program. At least
twenty percent of the program (measured by amount funded)
shall address the objective of identifying and evaluating
promising existing treatments, such as observation and pilot
studies. The program shall be submitted for determination of
scientific merit through independent peer review.